TSKU and neoplasm: Consistent with a TSK-fibrovascular niche, prominent TSK signaling to FB and Endo was mediated by several common ligand–receptor pairs, including VEGFA-NPR1, VEGFB-NPR1, PGF-SDC1, and CDH1-ITGAE, associated with tumor angiogenesis.